We are pleased to announce that the 20th Annual European Life Sciences CEO Forum (#Sachs_ELSF) will take place on the 3rd - 4th of March 2027 at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week (#SSLSW), which will also incorporate the 2nd Annual European Neuroscience Innovation Forum (#Sachs_ENIF). It will be held on the 2nd of March 2027, the day before ELSF, allowing relevant attendees to register for both events.
The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategies for 2027. The physical programme will consist of the usual panels and keynotes, which will be available on demand by the 11th of March. Additionally, there will be pre-arranged in-person meetings, live and on-demand company showcases, and a reception. During the Online Partnering week, virtual meetings will be available through the audio/video Online Meeting System.
The main programme for the 20th Annual ELSF is spread over 2 days (3rd - 4th of March) and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks, and advisors, with part of the audience participating virtually.
The In-Person meetings will take place on the 3rd - 4th of March, while virtual meetings will occur on the 9th - 11th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect around 2000 meetings to be completed during the event.
The conference will be held in the Central European Time Zone.
Panels & Sessions on the 3rd of March Include:
- BioPharma Industry Outlook Panel
- Venture & Private Equity Investor Dialogue Panel: Major Trends Including AI
- Platforms & Novel Therapeutics Panel: Emerging Opportunities
- Precision Immunology: Next-Generation Targets in Autoimmune & Inflammatory Care
- Rare & Orphan Disease Investment Panel: Riding the New Wave of Interest
- Targeted Radiopharmaceuticals: Isotope Supply Chains, Targets & Commercialisation
Panels & Sessions on the 4th of March Include:
- Dealmaking Dynamics: What Big Pharma Seeks in Early & Late-Stage Licensing
- Cross-Border Synergies: Greater China In-Licensing, Out-Licensing & Clinical Trials
- BD&L in Cancer Therapeutics: Asset Valuation & Strategic Co-Development
- Overcoming Resistance in Oncology: Multi-Target Therapeutics & Precision Medicine
- Early-Stage Biotech Survival: Capital Efficiency, Syndicate Building & De-Risking
- Rising Stars - Biotech Seed Companies Session
In-Person Meetings:
- 3rd - 4th of March
Online Virtual Meetings:
- 9th - 11th of March
Reception:
- Main Networking Reception – 3rd of March
- Farewell Reception – 4th of March
19th Annual European Life Sciences CEO Forum — Keynote Speakers Included:
19th Annual European Life Sciences CEO Forum — Chairs & Speakers Included:
19th Annual European Life Sciences CEO Forum — Presenting Companies Included:
Previous Highlights:
To learn more about presenting, exhibiting or sponsorship opportunities, please contact us at SachsTeam@SachsForum.com or call us on + 44 203 463 4890.